Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen-responsive POSLUMA-guided Intra-prostatic Boost (ARPEGGIO)

NCT07393867 is registered in ClinicalTrials.gov with Martin T. King, MD, PhD as lead sponsor.

NCT NCT07393867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07393867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen-responsive POSLUMA-guided Intra-prostatic Boost (ARPEGGIO)
Lead sponsor
Martin T. King, MD, PhD
Phase
Phase 2
Overall status
Recruiting
Start date
April 29, 2026
Completion date
December 15, 2027
Enrollment
23 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

high risk prostate cancer, intermediate risk prostate cancer, prostate cancer